{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T22:50:40Z","timestamp":1777416640289,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03031-y","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T21:56:49Z","timestamp":1754344609000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Leptomeningeal metastasis in triple-negative breast cancer: a retrospective study"],"prefix":"10.1007","volume":"16","author":[{"given":"Yun-Yi","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Han","family":"Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun-Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhong-Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"key":"3031_CR1","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s11060-017-2452-6","volume":"133","author":"E Le Rhun","year":"2017","unstructured":"Le Rhun E, et al. Diagnosis and treatment patterns for patients with leptomeningeal metastasis from solid tumors across Europe. J Neurooncol. 2017;133:419\u201327. https:\/\/doi.org\/10.1007\/s11060-017-2452-6.","journal-title":"J Neurooncol"},{"key":"3031_CR2","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/neuonc\/now183","volume":"19","author":"M Chamberlain","year":"2017","unstructured":"Chamberlain M, et al. Leptomeningeal metastases: a RANO proposal for response criteria. Neuro Oncol. 2017;19:484\u201392. https:\/\/doi.org\/10.1093\/neuonc\/now183.","journal-title":"Neuro Oncol"},{"key":"3031_CR3","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1093\/neuonc\/noac249","volume":"25","author":"N Lamba","year":"2023","unstructured":"Lamba N, et al. Incidence proportion and prognosis of leptomeningeal disease among patients with breast vs. non-breast primaries. Neuro Oncol. 2023;25:973\u201383. https:\/\/doi.org\/10.1093\/neuonc\/noac249.","journal-title":"Neuro Oncol"},{"key":"3031_CR4","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s10549-014-3054-z","volume":"146","author":"S Abouharb","year":"2014","unstructured":"Abouharb S, et al. Leptomeningeal disease and breast cancer: the importance of tumor subtype. Breast Cancer Res Treat. 2014;146:477\u201386. https:\/\/doi.org\/10.1007\/s10549-014-3054-z.","journal-title":"Breast Cancer Res Treat"},{"key":"3031_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11060-013-1092-8","volume":"113","author":"E Le Rhun","year":"2013","unstructured":"Le Rhun E, et al. A retrospective case series of 103 consecutive patients with leptomeningeal metastasis and breast cancer. J Neurooncol. 2013;113:83\u201392. https:\/\/doi.org\/10.1007\/s11060-013-1092-8.","journal-title":"J Neurooncol"},{"key":"3031_CR6","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.clbc.2016.07.014","volume":"16","author":"S Dudani","year":"2016","unstructured":"Dudani S, et al. Optimal management of leptomeningeal carcinomatosis in breast cancer patients\u2014a systematic review. Clin Breast Cancer. 2016;16:456\u201370. https:\/\/doi.org\/10.1016\/j.clbc.2016.07.014.","journal-title":"Clin Breast Cancer"},{"key":"3031_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.critrevonc.2019.01.020","volume":"135","author":"MA Franzoi","year":"2019","unstructured":"Franzoi MA, Hortobagyi GN. Leptomeningeal carcinomatosis in patients with breast cancer. Crit Rev Oncol Hematol. 2019;135:85\u201394. https:\/\/doi.org\/10.1016\/j.critrevonc.2019.01.020.","journal-title":"Crit Rev Oncol Hematol"},{"key":"3031_CR8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.2174\/187152411794961068","volume":"11","author":"F Meriggi","year":"2011","unstructured":"Meriggi F, Zaniboni A. Newer avenues for the treatment of leptomeningeal carcinomatosis. Cent Nerv Syst Agents Med Chem. 2011;11:38\u201344.","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"3031_CR9","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1212\/WNL.0b013e31828f183f","volume":"80","author":"L Nayak","year":"2013","unstructured":"Nayak L, et al. Rare cell capture technology for the diagnosis of leptomeningeal metastasis in solid tumors. Neurology. 2013;80:1598\u2013605. https:\/\/doi.org\/10.1212\/WNL.0b013e31828f183f. (discussion 1603).","journal-title":"Neurology"},{"key":"3031_CR10","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1093\/neuonc\/nox066","volume":"19","author":"X Lin","year":"2017","unstructured":"Lin X, et al. Cerebrospinal fluid circulating tumor cells: a novel tool to diagnose leptomeningeal metastases from epithelial tumors. Neuro Oncol. 2017;19:1248\u201354. https:\/\/doi.org\/10.1093\/neuonc\/nox066.","journal-title":"Neuro Oncol"},{"key":"3031_CR11","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s11060-020-03617-2","volume":"149","author":"M Seong","year":"2020","unstructured":"Seong M, et al. Diagnostic accuracy of MR imaging of patients with leptomeningeal seeding from lung adenocarcinoma based on 2017 RANO proposal: added value of contrast-enhanced 2D axial T2 FLAIR. J Neurooncol. 2020;149:367\u201372. https:\/\/doi.org\/10.1007\/s11060-020-03617-2.","journal-title":"J Neurooncol"},{"key":"3031_CR12","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.5858\/134.7.e48","volume":"134","author":"MEH Hammond","year":"2010","unstructured":"Hammond MEH, et al. American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). Arch Pathol Lab Med. 2010;134:e48\u201372.","journal-title":"Arch Pathol Lab Med"},{"key":"3031_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2023.101624","volume":"8","author":"E Le Rhun","year":"2023","unstructured":"Le Rhun E, et al. Leptomeningeal metastasis from solid tumours: EANO-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. ESMO Open. 2023;8: 101624. https:\/\/doi.org\/10.1016\/j.esmoop.2023.101624.","journal-title":"ESMO Open"},{"key":"3031_CR14","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.ccell.2019.02.001","volume":"35","author":"YZ Jiang","year":"2019","unstructured":"Jiang YZ, et al. Genomic and transcriptomic landscape of triple-negative breast cancers: subtypes and treatment strategies. Cancer Cell. 2019;35:428-440.e425. https:\/\/doi.org\/10.1016\/j.ccell.2019.02.001.","journal-title":"Cancer Cell"},{"key":"3031_CR15","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s11060-018-2790-z","volume":"138","author":"A Niwi\u0144ska","year":"2018","unstructured":"Niwi\u0144ska A, Pogoda K, Michalski W, Kunkiel M, Jagie\u0142\u0142o-Gruszfeld A. Determinants of prolonged survival for breast cancer patient groups with leptomeningeal metastasis (LM). J Neurooncol. 2018;138:191\u20138. https:\/\/doi.org\/10.1007\/s11060-018-2790-z.","journal-title":"J Neurooncol"},{"key":"3031_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","volume":"19","author":"G Bianchini","year":"2022","unstructured":"Bianchini G, De Angelis C, Licata L, Gianni L. Treatment landscape of triple-negative breast cancer\u2014expanded options, evolving needs. Nat Rev Clin Oncol. 2022;19:91\u2013113. https:\/\/doi.org\/10.1038\/s41571-021-00565-2.","journal-title":"Nat Rev Clin Oncol"},{"key":"3031_CR17","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1093\/clinchem\/hvac127","volume":"68","author":"A Darlix","year":"2022","unstructured":"Darlix A, et al. Detection of circulating tumor cells in cerebrospinal fluid of patients with suspected breast cancer leptomeningeal metastases: a prospective study. Clin Chem. 2022;68:1311\u201322. https:\/\/doi.org\/10.1093\/clinchem\/hvac127.","journal-title":"Clin Chem"},{"key":"3031_CR18","doi-asserted-by":"crossref","unstructured":"DeAngelis LM, Posner JB. Neurologic complications of cancer. Vol. 73 (OUP USA, 2009).","DOI":"10.1093\/med\/9780195366747.001.0001"},{"key":"3031_CR19","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1212\/WNL.0b013e3181dc1a69","volume":"74","author":"JL Clarke","year":"2010","unstructured":"Clarke JL, Perez HR, Jacks LM, Panageas KS, Deangelis LM. Leptomeningeal metastases in the MRI era. Neurology. 2010;74:1449\u201354. https:\/\/doi.org\/10.1212\/WNL.0b013e3181dc1a69.","journal-title":"Neurology"},{"key":"3031_CR20","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1007\/s004150050459","volume":"246","author":"CS Straathof","year":"1999","unstructured":"Straathof CS, de Bruin HG, Dippel DW, Vecht CJ. The diagnostic accuracy of magnetic resonance imaging and cerebrospinal fluid cytology in leptomeningeal metastasis. J Neurol. 1999;246:810\u20134.","journal-title":"J Neurol"},{"key":"3031_CR21","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1093\/annonc\/mdq232","volume":"21","author":"H Gauthier","year":"2010","unstructured":"Gauthier H, et al. Survival of breast cancer patients with meningeal carcinomatosis. Ann Oncol. 2010;21:2183\u20137. https:\/\/doi.org\/10.1093\/annonc\/mdq232.","journal-title":"Ann Oncol"},{"key":"3031_CR22","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s11060-010-0524-y","volume":"104","author":"CRAS de Azevedo","year":"2011","unstructured":"de Azevedo CRAS, et al. Meningeal carcinomatosis in breast cancer: prognostic factors and outcome. J Neurooncol. 2011;104:565\u201372. https:\/\/doi.org\/10.1007\/s11060-010-0524-y.","journal-title":"J Neurooncol"},{"key":"3031_CR23","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/neuonc\/noy186","volume":"21","author":"L Angus","year":"2019","unstructured":"Angus L, et al. Novel methods to diagnose leptomeningeal metastases in breast cancer. Neuro Oncol. 2019;21:428\u201339. https:\/\/doi.org\/10.1093\/neuonc\/noy186.","journal-title":"Neuro Oncol"},{"key":"3031_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.clbc.2016.07.002","volume":"17","author":"A Morikawa","year":"2017","unstructured":"Morikawa A, et al. Characteristics and outcomes of patients with breast cancer with leptomeningeal metastasis. Clin Breast Cancer. 2017;17:23\u20138. https:\/\/doi.org\/10.1016\/j.clbc.2016.07.002.","journal-title":"Clin Breast Cancer"},{"key":"3031_CR25","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1053\/j.seminoncol.2009.05.005","volume":"36","author":"MC Chamberlain","year":"2009","unstructured":"Chamberlain MC, Glantz M, Groves MD, Wilson WH. Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment. Semin Oncol. 2009;36:S35\u201345. https:\/\/doi.org\/10.1053\/j.seminoncol.2009.05.005.","journal-title":"Semin Oncol"},{"key":"3031_CR26","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/ana.410380111","volume":"38","author":"RJ Freilich","year":"1995","unstructured":"Freilich RJ, Krol G, DeAngelis LM. Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis. Ann Neurol. 1995;38:51\u20137.","journal-title":"Ann Neurol"},{"key":"3031_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-022-04118-0","author":"P Palmisciano","year":"2022","unstructured":"Palmisciano P, et al. Intrathecal therapy for the management of leptomeningeal metastatic disease: a scoping review of the current literature and ongoing clinical trials. J Neurooncol. 2022. https:\/\/doi.org\/10.1007\/s11060-022-04118-0.","journal-title":"J Neurooncol"},{"key":"3031_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100150","volume":"6","author":"M Carausu","year":"2021","unstructured":"Carausu M, et al. Breast cancer patients treated with intrathecal therapy for leptomeningeal metastases in a large real-life database. ESMO Open. 2021;6: 100150. https:\/\/doi.org\/10.1016\/j.esmoop.2021.100150.","journal-title":"ESMO Open"},{"key":"3031_CR29","first-page":"444","volume":"8","author":"MS Edwards","year":"1981","unstructured":"Edwards MS, Levin VA, Seager ML, Wilson CB. Intrathecal chemotherapy for leptomeningeal dissemination of medulloblastoma. Childs Brain. 1981;8:444\u201351.","journal-title":"Childs Brain"},{"key":"3031_CR30","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1200\/JCO.1987.5.10.1655","volume":"5","author":"RN Hitchins","year":"1987","unstructured":"Hitchins RN, Bell DR, Woods RL, Levi JA. A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis. J Clin Oncol. 1987;5:1655\u201362.","journal-title":"J Clin Oncol"},{"key":"3031_CR31","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/jjco\/hyg118","volume":"33","author":"D-Y Kim","year":"2003","unstructured":"Kim D-Y, et al. Comparison of intrathecal chemotherapy for leptomeningeal carcinomatosis of a solid tumor: methotrexate alone versus methotrexate in combination with cytosine arabinoside and hydrocortisone. Jpn J Clin Oncol. 2003;33:608\u201312.","journal-title":"Jpn J Clin Oncol"},{"key":"3031_CR32","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1002\/(SICI)1097-0142(19980501)82:9<1764::AID-CNCR24>3.0.CO;2-1","volume":"82","author":"F Bokstein","year":"1998","unstructured":"Bokstein F, Lossos A, Siegal T. Leptomeningeal metastases from solid tumors: a comparison of two prospective series treated with and without intra-cerebrospinal fluid chemotherapy. Cancer. 1998;82:1756\u201363.","journal-title":"Cancer"},{"key":"3031_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2023.102597","volume":"119","author":"N Epaillard","year":"2023","unstructured":"Epaillard N, Bassil J, Pistilli B. Current indications and future perspectives for antibody-drug conjugates in brain metastases of breast cancer. Cancer Treat Rev. 2023;119: 102597. https:\/\/doi.org\/10.1016\/j.ctrv.2023.102597.","journal-title":"Cancer Treat Rev"},{"key":"3031_CR34","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s10549-016-3828-6","volume":"157","author":"W Jacot","year":"2016","unstructured":"Jacot W, et al. Efficacy and safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer with brain metastases. Breast Cancer Res Treat. 2016;157:307\u201318. https:\/\/doi.org\/10.1007\/s10549-016-3828-6.","journal-title":"Breast Cancer Res Treat"},{"key":"3031_CR35","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/cncr.24041","volume":"115","author":"J Bruna","year":"2009","unstructured":"Bruna J, et al. Leptomeningeal carcinomatosis: prognostic implications of clinical and cerebrospinal fluid features. Cancer. 2009;115:381\u20139. https:\/\/doi.org\/10.1002\/cncr.24041.","journal-title":"Cancer"},{"key":"3031_CR36","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/JTO.0b013e3182773f21","volume":"8","author":"SJ Lee","year":"2013","unstructured":"Lee SJ, et al. Leptomeningeal carcinomatosis in non-small-cell lung cancer patients: impact on survival and correlated prognostic factors. J Thorac Oncol. 2013;8:185\u201391. https:\/\/doi.org\/10.1097\/JTO.0b013e3182773f21.","journal-title":"J Thorac Oncol"},{"key":"3031_CR37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.clineuro.2012.03.048","volume":"115","author":"J-A Palma","year":"2013","unstructured":"Palma J-A, et al. Leptomeningeal carcinomatosis: prognostic value of clinical, cerebrospinal fluid, and neuroimaging features. Clin Neurol Neurosurg. 2013;115:19\u201325. https:\/\/doi.org\/10.1016\/j.clineuro.2012.03.048.","journal-title":"Clin Neurol Neurosurg"},{"key":"3031_CR38","doi-asserted-by":"publisher","DOI":"10.1093\/med\/9780195366747.001.0001","volume-title":"Neurologic complications of cancer","author":"LM DeAngelis","year":"2008","unstructured":"DeAngelis LM, Posner JB. Neurologic complications of cancer. Oxford: Oxford University Press; 2008."}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03031-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03031-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03031-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T16:31:50Z","timestamp":1757349110000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03031-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3031"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03031-y","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,4]]},"assertion":[{"value":"5 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Committee of Fudan University Shanghai Cancer Center (Ethics Approval Number: 050432-4-2307E) in accordance with the ethical standards of the institutional research committee and the 1964 Helsinki Declaration and its later amendments. Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1470"}}